Denali Therapeutics Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 13.79 M | $401.66 M | 100.00% | 8.14% |
BAILLIE GIFFORD & CO | 11/05/2024 | 13.35 M | $388.77 M | -3.03% | 7.88% |
VANGUARD GROUP INC | 11/13/2024 | 11.18 M | $325.59 M | -1.20% | 6.60% |
WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 10.73 M | $312.49 M | 9.20% | 6.33% |
CAPITAL RESEARCH GLOBAL INVESTORS | 11/13/2024 | 7.91 M | $230.39 M | 10.98% | 4.67% |
FMR LLC | 11/13/2024 | 7.83 M | $228.13 M | 3,234.35% | 4.62% |
TEMASEK HOLDINGS (PRIVATE) LTD | 11/14/2024 | 5.36 M | $156.02 M | -6.14% | 3.16% |
CRESTLINE MANAGEMENT, LP | 11/13/2024 | 4.46 M | $129.94 M | -6.30% | 2.63% |
STATE STREET CORP | 11/14/2024 | 4.25 M | $123.86 M | -4.12% | 2.51% |
BAKER BROS. ADVISORS LP | 11/14/2024 | 3.73 M | $108.70 M | 0.00% | 2.20% |
ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 3.05 M | $88.77 M | 50.96% | 1.80% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 2.96 M | $86.11 M | -0.91% | 1.74% |
PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 2.87 M | $83.60 M | 27.24% | 1.69% |
CAMBER CAPITAL MANAGEMENT LP | 11/14/2024 | 2.00 M | $58.26 M | 0.00% | 1.18% |
MARSHALL WACE, LLP | 11/14/2024 | 1.97 M | $57.30 M | -18.67% | 1.16% |
MORGAN STANLEY | 11/14/2024 | 1.74 M | $50.82 M | 42.56% | 1.03% |
DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 1.56 M | $45.43 M | 10.02% | 0.92% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 1.37 M | $39.84 M | 12.22% | 0.81% |
BANK OF NEW YORK MELLON CORP | 11/12/2024 | 1.33 M | $38.75 M | -13.63% | 0.79% |
PRINCIPAL FINANCIAL GROUP INC | 10/31/2024 | 1.24 M | $36.08 M | 13.77% | 0.73% |
ARTISAN PARTNERS LIMITED PARTNERSHIP | 11/12/2024 | 1.09 M | $31.78 M | -4.42% | 0.64% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 1.02 M | $29.59 M | -4.11% | 0.60% |
CASDIN CAPITAL, LLC | 11/14/2024 | 990,000 | $28.84 M | -23.85% | 0.58% |
CANDRIAM S.C.A. | 11/13/2024 | 942,158 | $27.44 M | 29.68% | 0.56% |
SIREN, L.L.C. | 11/13/2024 | 834,028 | $24.30 B | 100.00% | 0.49% |
CITADEL ADVISORS LLC | 11/14/2024 | 777,280 | $22.64 M | -36.22% | 0.46% |
NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 715,300 | $20.84 M | -33.39% | 0.42% |
CERCANO MANAGEMENT LLC | 11/14/2024 | 625,000 | $18.21 M | 0.00% | 0.37% |
YIHENG CAPITAL MANAGEMENT, L.P. | 11/12/2024 | 600,098 | $17.48 M | -47.85% | 0.35% |
FISHER ASSET MANAGEMENT, LLC | 11/12/2024 | 547,331 | $15.94 M | 14.48% | 0.32% |
AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 451,374 | $13.15 M | -13.63% | 0.27% |
CLARIUS GROUP, LLC | 10/09/2024 | 409,995 | $11.94 M | 0.00% | 0.24% |
JANE STREET GROUP, LLC | 11/15/2024 | 369,671 | $10.77 M | 59.78% | 0.22% |
ABRDN PLC | 10/25/2024 | 363,679 | $10.59 M | -36.53% | 0.21% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 348,164 | $10.14 M | -53.08% | 0.21% |
ENSIGN PEAK ADVISORS, INC | 11/14/2024 | 346,304 | $10.09 M | 0.00% | 0.20% |
AXA S.A. | 11/14/2024 | 344,883 | $10.05 M | 0.03% | 0.20% |
POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 333,530 | $9.72 M | -68.33% | 0.20% |
STEMPOINT CAPITAL LP | 11/13/2024 | 282,050 | $8.22 M | 12.37% | 0.17% |
BARCLAYS PLC | 11/19/2024 | 255,883 | $7.45 M | 101.39% | 0.15% |
SWISS NATIONAL BANK | 11/07/2024 | 250,700 | $7.30 M | 7.69% | 0.15% |
TD ASSET MANAGEMENT INC | 11/01/2024 | 244,552 | $7.20 M | 36.51% | 0.14% |
WASATCH ADVISORS LP | 11/14/2024 | 238,881 | $6.96 M | -40.64% | 0.14% |
JPMORGAN CHASE & CO | 12/26/2024 | 235,386 | $6.86 M | 6.48% | 0.14% |
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | 11/18/2024 | 207,124 | $6.03 M | 0.00% | 0.12% |
MANUFACTURERS LIFE INSURANCE COMPANY, THE | 11/13/2024 | 206,819 | $6.02 M | 20.05% | 0.12% |
INVESCO LTD. | 11/12/2024 | 206,363 | $6.01 M | 77.54% | 0.12% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 11/14/2024 | 205,680 | $5.99 M | 0.00% | 0.12% |
RHUMBLINE ADVISERS | 11/12/2024 | 189,893 | $5.53 M | -2.55% | 0.11% |
PIER CAPITAL, LLC | 11/15/2024 | 168,082 | $4.90 M | 1.57% | 0.10% |
Denali Therapeutics Inc.institutional Ownership - FAQ's
During the previous two years, 261 institutional investors and hedge funds held shares of Denali Therapeutics Inc.. The most heavily invested institutionals were:
AdvisorNet Financial, Inc: 0
BlackRock Funding, Inc. /DE: 13.79 M
BAILLIE GIFFORD & CO: 13.35 M
VANGUARD GROUP INC: 11.18 M
WELLINGTON MANAGEMENT GROUP LLP: 10.73 M
Capital Research Global Investors: 7.91 M
74.56% of Denali Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 139.84 M shares in the last 24 months. This purchase volume represents approximately $2.62 B in transactions.